[contact-form-7 id="15592" title="Tell me more"]

Contact Next Edge Capital

1 Toronto Street, Suite 200
Toronto, ON M5C 2V6

Telephone: 416.775.3600
Toll-free: 1.877.860.1080
Fax: 416.775.3601
Email: info@nextedgecapital.com

How to reduce risk when investing in biotech stocks

Eden Rahim, the portfolio manager and options strategist at Next Edge Capital, joins BNN Bloomberg and discusses the steep decline in biotech stocks, how to reduce the risk when investing in the sector, and several Canadian names that are attractive opportunities....

Read More
U.S. Midterm & Health-care and Biotech

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, joins BNN Bloomberg to provide insight on what the U.S. midterm elections could mean for the health-care and biotech sectors....

Read More
A Blowout Performance Without A FAANG In Sight

The second-best performing mutual fund in the country over the past 12 months does not contain a single share from the high-flying FAANG stocks. Eden Rahim of Next Edge Capital explains how his Next Edge Bi0TEch Plus A fund shot up 47 per cent over...

Read More
Eden Rahim On The line with BNN

Eden Rahim, portfolio manager and options strategist, Next Edge Capital joins BNN to discuss U.S. President Donald Trump’s meeting with U.S. drug makers....

Read More
Best Buying Opportunity in 22 Years

Eden Rahim, portfolio manager and options strategist at Next Edge Capital, says the buying opportunity in late-stage biotech stocks is the best he’s ever seen. We talk valuations, takeover activity, drug discovery and Rahim’s top picks which include Acadia Pharmaceuticals, Portola Pharma and Neurocrine Bioscience....

Read More